Research status and progress of deep learning in automatic esophageal cancer detection.

Journal: World journal of gastrointestinal oncology
Published Date:

Abstract

Esophageal cancer (EC), a common malignant tumor of the digestive tract, requires early diagnosis and timely treatment to improve patient prognosis. Automated detection of EC using medical imaging has the potential to increase screening efficiency and diagnostic accuracy, thereby significantly improving long-term survival rates and the quality of life of patients. Recent advances in deep learning (DL), particularly convolutional neural networks, have demonstrated remarkable performance in medical imaging analysis. These techniques have shown significant progress in the automated identification of malignant tumors, quantitative analysis of lesions, and improvement in diagnostic accuracy and efficiency. This article comprehensively examines the research progress of DL in medical imaging for EC, covering various imaging modalities such as digital pathology, endoscopy, computed tomography, It explores the clinical value and application prospects of DL in EC screening and diagnosis. Additionally, the article addresses several critical challenges that must be overcome for the clinical translation of DL techniques, including constructing high-quality datasets, promoting multimodal feature fusion, and optimizing artificial intelligence-clinical workflow integration. By providing a detailed overview of the current state of DL in EC imaging and highlighting the key challenges and future directions, this article aims to guide future research and facilitate the clinical implementation of DL technologies in EC management, ultimately contributing to better patient outcomes.

Authors

  • Jing Chen
    Department of Vascular Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, P.R. China.
  • Xin Fan
    School of Software Technology, Dalian University of Technology, Dalian, 116024, China; Key Laboratory for Ubiquitous Network and Service Software of Liaoning Province, Dalian University of Technology, Dalian, 116024, China. Electronic address: xin.fan@ieee.org.
  • Qiao-Liang Chen
    Department of Nuclear Medicine, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210008, Jiangsu Province, China.
  • Wei Ren
    Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Department of Medical Oncology, Breast Tumor Centre, Phase I Clinical Trial Centre, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
  • Qi Li
    The First Affiliated Hospital of Yangtze University, Jingzhou, Hubei, China.
  • Dong Wang
    Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin, China.
  • Jian He
    School of Software Engineering, Beijing University of Technology, Beijing, China. Electronic address: jianhee@bjut.edu.cn.

Keywords

No keywords available for this article.